PharmacoEconomics & Outcomes News

, Volume 589, Issue 1, pp 4–4 | Cite as

Insulin aspart looks good for T2DM in Japan

Clinical study


  1. 1.
    Pollock RF, Valentine WJ, THOMSEN TL, Nishimura H.Use of rapid-acting insulin aspart reduces costs and cardiovascular complications in type 2 diabetes when compared with human insulin. 45th Annual Meeting of the European Association for the Study of Diabetes: abstr. 891, 30 Sep 2009. Available from: URL:

Copyright information

© Adis International Ltd 2009

Personalised recommendations